Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

71%

5 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

4(66.7%)

Phase 4

1(16.7%)

Phase 2

1(16.7%)

6Total

Phase 3(4)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03802617Phase 2Completed

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Role: collaborator

NCT04040439Completed

Precedex Special Investigation (in Pediatric Patients)

Role: collaborator

NCT01438957Phase 3Completed

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation

Role: collaborator

NCT02757625Phase 3Completed

Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit

Role: collaborator

NCT00318955Phase 4Completed

Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients

Role: collaborator

NCT01438931Phase 3Completed

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation

Role: collaborator

NCT00526760Phase 3Completed

Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects

Role: collaborator

All 7 trials loaded